Patents by Inventor Kelly Watters

Kelly Watters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT CDHR3 PROTEIN FRAGMENTS INHIBIT RHINOVIRUS C BINDING AND REPLICATION
    Publication number: 20240109948
    Abstract: The present invention provides soluble truncated peptides of CDHR3, recombinant variants thereof and methods of making these peptides. The present invention also provide methods of inhibiting rhinovirus C infection and an in vitro assay for screening for anti-viral agents against rhinovirus C.
    Type: Application
    Filed: April 25, 2023
    Publication date: April 4, 2024
    Inventors: Ann Carol Palmenberg, Kelly Watters
  • Recombinant CDHR3 protein fragments inhibit rhinovirus C binding and replication
    Patent number: 11667690
    Abstract: The present invention provides soluble truncated peptides of CDHR3, recombinant variants thereof and methods of making these peptides. The present invention also provide methods of inhibiting rhinovirus C infection and an in vitro assay for screening for anti-viral agents against rhinovirus C.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: June 6, 2023
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Ann Carol Palmenberg, Kelly Watters
  • RECOMBINANT CDHR3 PROTEIN FRAGMENTS INHIBIT RHINOVIRUS C BINDING AND REPLICATION
    Publication number: 20210214413
    Abstract: The present invention provides soluble truncated peptides of CDHR3, recombinant variants thereof and methods of making these peptides. The present invention also provide methods of inhibiting rhinovirus C infection and an in vitro assay for screening for anti-viral agents against rhinovirus C.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 15, 2021
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Ann Carol Palmenberg, Kelly Watters